Journal of Advanced Research in Biochemistry and Pharmacology
http://medicaljournalshouse.com/index.php/ADR-Pharmacology_Biochemistry
Journal of Advanced Research in Biochemistry & PharmacologyAdvanced Research Publicationsen-USJournal of Advanced Research in Biochemistry and Pharmacology<p>We, the undersigned, give an undertaking to the following effect with regard to our article entitled<br>“_______________________________________________________________________________________________________________________________________________________________________________<br>________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-</p> <p>1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.</p> <p>2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.</p> <p>3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.</p> <p>4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.</p> <p>5. I/We also agree to the authorship of the article in the following sequence:-</p> <p>Authors' Names (in sequence) Signature of Authors<br>1. _____________________________________ _____________________________________<br>2. _____________________________________ _____________________________________<br>3. _____________________________________ _____________________________________<br>4. _____________________________________ _____________________________________<br>5. _____________________________________ _____________________________________<br>6. _____________________________________ _____________________________________<br>7. _____________________________________ _____________________________________<br>8. _____________________________________ _____________________________________</p> <p>Important</p> <p>(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.</p> <p>(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.</p> <p>(iii). If the authorship is contested at any stage, the article will be either returned or will not be<br>processed for publication till the issue is solved.</p>Biochemical Formulations: Integrating Technology and Healthcare
http://medicaljournalshouse.com/index.php/ADR-Pharmacology_Biochemistry/article/view/1362
<p> In the evolving landscape of healthcare, the integration of technology with biochemical formulations represents a paradigm shift towards personalized and precision medicine. This abstract explores the intersection of technology and healthcare through the lens of biochemical formulations, emphasizing their role in diagnostics, treatment, and patient care. Biochemical formulations encompass a wide array of pharmaceuticals, from traditional small molecules to biologics and nanomedicines, each tailored to interact with specific biological targets or pathways. The integration of advanced technologies, such as artificial intelligence, genomic profiling, and targeted drug delivery systems, enhances the efficacy and safety of biochemical formulations while optimizing treatment outcomes. Moreover, these innovations facilitate real-time monitoring of biochemical markers, enabling clinicians to tailor therapies based on individual patient characteristics and disease profiles.</p> <p>How to cite this article:<br />Waheed A, Khan N, Gul H, et al. Biochemical <br />Formulations: Integrating Technology and <br />Healthcare. J Adv Res Biochem Pharma 2024; <br />7(1): 6-12.</p>Abdul WaheedNadia Khan Hina GulSeemab Ali
Copyright (c) 2024 Journal of Advanced Research in Biochemistry and Pharmacology
http://creativecommons.org/licenses/by-nc/4.0
2024-10-092024-10-0971 Antibacterial and Cytotoxic Properties of Terminalia chebula Fruits
http://medicaljournalshouse.com/index.php/ADR-Pharmacology_Biochemistry/article/view/1363
<p> Terminalia chebula fruits are recognized for their potent antibacterial and cytotoxic properties, offering significant potential as sources of bioactive compounds for therapeutic use. These fruits exhibit robust antibacterial activity against a wide array of pathogenic bacteria, encompassing both Gram-positive and Gram-negative species. The efficacy is attributed to their rich composition of tannins, flavonoids, and phenolic acids, which disrupt bacterial cell walls, inhibit essential enzymes, and chelate vital metal ions crucial for bacterial growth. This multifaceted approach not only curtails bacterial proliferation but also mitigates the risk of antibiotic resistance development. Moreover, Terminalia chebula enhances the effectiveness of conventional antibiotics through synergistic interactions, promising more efficacious treatments for bacterial infections. On the cytotoxic front, Terminalia chebula demonstrates potent activity against diverse cancer cell lines, including those associated with breast, colon, and liver cancers. Mechanistically, the fruits induce apoptosis via caspase activation and mitochondrial pathways, facilitated by key compounds such as chebulagic acid, chebulinic acid, and ellagic acid.</p> <p>How to cite this article:<br />Mukherji A, Gosh D. Antibacterial and Cytotoxic <br />Properties of Terminalia chebula Fruits. J Adv Res <br />Biochem Pharma 2024; 7(1): 1-5.</p>Akansha MukherjiDevaditya Gosh
Copyright (c) 2024 Journal of Advanced Research in Biochemistry and Pharmacology
http://creativecommons.org/licenses/by-nc/4.0
2024-10-092024-10-0971 Melatonin and Its Impact on Circadian Rhythms and Sleep
http://medicaljournalshouse.com/index.php/ADR-Pharmacology_Biochemistry/article/view/1365
<p> Melatonin, synthesized primarily in the pineal gland, acts as a biological signal synchronized to the day-night cycle, influencing various physiological processes through interactions with MT1 and MT2 receptors. By modulating clock gene expression in the Suprachiasmatic Nucleus (SCN), melatonin plays a pivotal role in maintaining robust circadian rhythms governing sleep-wake cycles, hormone secretion, and metabolic functions. Beyond its chronobiotic effects, melatonin <br />enhances sleep quality by promoting sleep onset and optimizing sleep architecture, including Rapid Eye Movement (REM) and Slow-Wave Sleep (SWS) stages. Clinical applications of melatonin extend to managing sleep disorders, circadian rhythm disturbances, and conditions associated with oxidative stress and neurodegeneration. Understanding melatonin’s mechanisms of action provides insights into its therapeutic potential and underscores its role in optimizing sleep health and overall well-being.</p> <p>How to cite this article:<br />Agung, Bayu, Fadhlan. Melatonin and Its Impact <br />on Circadian Rhythms and Sleep. J Adv Res <br />Biochem Pharma 2024; 7(1): 200-00.</p>Agung BayuFadhlan
Copyright (c) 2024 Journal of Advanced Research in Biochemistry and Pharmacology
http://creativecommons.org/licenses/by-nc/4.0
2024-10-092024-10-0971 Plant-Based Anti-inflammatory Compounds: Current Research and Applications
http://medicaljournalshouse.com/index.php/ADR-Pharmacology_Biochemistry/article/view/1364
Abdul Rahman Mahmoud YusufMustafa khalid
Copyright (c) 2024 Journal of Advanced Research in Biochemistry and Pharmacology
http://creativecommons.org/licenses/by-nc/4.0
2024-10-092024-10-0971 Quantitative Analysis of Antioxidant Biomarkers in Cucumis Melo Var. Agrestis Leaves Using a Validated Hptlc Technique
http://medicaljournalshouse.com/index.php/ADR-Pharmacology_Biochemistry/article/view/1361
<p><strong> Background: </strong>This study focused on using the HPTLC method for the simultaneous estimation of natural antioxidant markers, specifically rutin, gallic acid, and quercetin, from the plant extract of Cucumis melo var. agrestis (CME).<br /><strong>Aims and Objectives:</strong> The primary objective of this research was to extract and simultaneously quantify the three antioxidant markers— rutin, gallic acid, and quercetin—from CME using normal phase HPTLC.<br /><strong>Materials and Methods:</strong> Compounds were separated on TLC aluminum plates precoated with silica 60 F 260, followed by the detection of rutin, gallic acid, and quercetin. Densitometric scanning at 250 nm was performed using a Camag TLC scanner 3 equipped with winCATS software. This method was further validated for linearity, precision, accuracy, and sensitivity according to ICH guidelines.<br /><strong>Results:</strong> The calibration plots showed a strong linear relationship with R2 values of 0.982, 0.9892, and 0.9860 for rutin, gallic acid, and quercetin, respectively. Accuracy was assessed through recovery studies at three different levels, yielding an average recovery rate between 95% and 98% for all three markers.<br /><strong>Conclusion:</strong> The developed HPTLC method is suitable for detecting antioxidant markers in botanicals and herbal formulations.</p> <p>How to cite this article:<br />Quantitative Analysis of Antioxidant Biomarkers <br />in Cucumis Melo Var. Agrestis Leaves Using a <br />Validated Hptlc Technique. J Adv Res Biochem <br />Pharma 2024; 7(1): 30-0.</p> Varun NaikVijay Shinde
Copyright (c) 2024 Journal of Advanced Research in Biochemistry and Pharmacology
http://creativecommons.org/licenses/by-nc/4.0
2024-10-092024-10-0971